Literature DB >> 6606472

The risk of developing ankylosing spondylitis in HLA-B27 positive individuals: a family and population study.

S van der Linden, H Valkenburg, A Cats.   

Abstract

In a family study, sacroiliitis was found in 15 (25%) out of 61 HLA-B27 positive first-degree relatives (FDR) of 20 randomly chosen HLA-B27 positive ankylosing spondylitis (AS) patients and never in 41 HLA-B27 negative FDR. Eight (53%) of the 15 FDR with sacroiliitis fulfilled the New York criteria for AS. In the population study the prevalence of HLA-B27 positive AS was found to be 0.1%. AS will develop in 1.3% of all HLA-B27 positive individuals belonging to the general population.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6606472     DOI: 10.1093/rheumatology/xxii.suppl_2.18

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  23 in total

1.  Recurrence risk modelling of the genetic susceptibility to ankylosing spondylitis.

Authors:  M A Brown; S H Laval; S Brophy; A Calin
Journal:  Ann Rheum Dis       Date:  2000-11       Impact factor: 19.103

Review 2.  Early referral recommendations for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary care.

Authors:  J Sieper; M Rudwaleit
Journal:  Ann Rheum Dis       Date:  2004-11-04       Impact factor: 19.103

3.  Frequency of mutated allele CYP2D6*4 in the Turkish ankylosing spondylitis patients and healthy controls.

Authors:  Gonul Erden; Filiz Sivas Acar; Esra Erkol Inal; Ayse Ozden Soydas; Kursat Ozoran; Hatice Bodur; Metin Mustafa Yildirimkaya
Journal:  Rheumatol Int       Date:  2009-02-26       Impact factor: 2.631

4.  A polymorphism in ERAP1 is associated with susceptibility to ankylosing spondylitis in a Turkish population.

Authors:  Muhammet Cinar; Hatice Akar; Sedat Yilmaz; Ismail Simsek; Mutlu Karkucak; Rahsan Ilıkci Sagkan; Aysel Pekel; Hakan Erdem; Ismail Yasar Avci; Cengizhan Acikel; Ugur Musabak; Yusuf Tunca; Salih Pay
Journal:  Rheumatol Int       Date:  2013-07-18       Impact factor: 2.631

Review 5.  Biomarker development for axial spondyloarthritis.

Authors:  Matthew A Brown; Zhixiu Li; Kim-Anh Lê Cao
Journal:  Nat Rev Rheumatol       Date:  2020-06-30       Impact factor: 20.543

6.  Whole-genome screening in ankylosing spondylitis: evidence of non-MHC genetic-susceptibility loci.

Authors:  S H Laval; A Timms; S Edwards; L Bradbury; S Brophy; A Milicic; L Rubin; K A Siminovitch; D E Weeks; A Calin; B P Wordsworth; M A Brown
Journal:  Am J Hum Genet       Date:  2001-02-27       Impact factor: 11.025

7.  Association of variants in 21q22 with ankylosing spondylitis in the Chinese Guangxi Zhuang population.

Authors:  Jinsong Yang; Qian Zhao; Chuangye Han; Chunjie Zhao; Li Zheng; Xin Zhang; Liumei Liu; Heyu Wei; Fanyue Zeng; Yuan Yang; Wei Su; Qikai Hua; Xinli Zhan; Qianfen Chen; Tingsong Li; Jun Liao; Hao Wu; Jinmin Zhao
Journal:  Rheumatol Int       Date:  2014-03-19       Impact factor: 2.631

Review 8.  Role of Human Leukocyte Antigens (HLA) in Autoimmune Diseases.

Authors:  Gergely Bodis; Victoria Toth; Andreas Schwarting
Journal:  Rheumatol Ther       Date:  2018-03-07

Review 9.  Genetics of ankylosing spondylitis--insights into pathogenesis.

Authors:  Matthew A Brown; Tony Kenna; B Paul Wordsworth
Journal:  Nat Rev Rheumatol       Date:  2015-10-06       Impact factor: 20.543

Review 10.  Progress in spondylarthritis. Progress in studies of the genetics of ankylosing spondylitis.

Authors:  Matthew A Brown
Journal:  Arthritis Res Ther       Date:  2009-10-29       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.